Neogen Corp financial data

Symbol
NEOG on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
620 Lesher Place, Lansing, MI
State of incorporation
MI
Fiscal year end
May 31
Latest financial report
10-Q - Q3 2024 - Oct 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 385 % -11.6%
Quick Ratio 120 % +17.1%
Debt-to-equity 45.1 % -0.68%
Return On Equity -0.75 % +11.8%
Return On Assets -0.52 % +12%
Operating Margin 4.58 % -16.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 217M shares +0.18%
Common Stock, Shares, Outstanding 217M shares +0.18%
Entity Public Float 3.25B USD -8.89%
Common Stock, Value, Issued 34.7M USD +0.18%
Weighted Average Number of Shares Outstanding, Basic 217M shares +0.18%
Weighted Average Number of Shares Outstanding, Diluted 217M shares -0.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 912M USD -0.75%
Research and Development Expense 21M USD -24.8%
Selling and Marketing Expense 183M USD +11.8%
General and Administrative Expense 206M USD -5.46%
Operating Income (Loss) 41.8M USD -17.4%
Nonoperating Income (Expense) -73.4M USD +5.49%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.6M USD -16.8%
Income Tax Expense (Benefit) -8.04M USD -1641%
Net Income (Loss) Attributable to Parent -23.5M USD +11.5%
Earnings Per Share, Basic -0.11 USD/shares +31.3%
Earnings Per Share, Diluted -0.11 USD/shares +31.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120M USD -32.6%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 168M USD +21.8%
Inventory, Net 199M USD +41.2%
Assets, Current 541M USD -7.39%
Deferred Income Tax Assets, Net 3.79M USD +13%
Property, Plant and Equipment, Net 301M USD +36.1%
Operating Lease, Right-of-Use Asset 14.3M USD -1.34%
Intangible Assets, Net (Excluding Goodwill) 1.49B USD -6.19%
Goodwill 2.14B USD -0.01%
Other Assets, Noncurrent 20M USD +24.6%
Assets 4.5B USD -1.27%
Accounts Payable, Current 61.5M USD -31.9%
Employee-related Liabilities, Current 15.8M USD +6.32%
Liabilities, Current 123M USD -11.2%
Deferred Income Tax Liabilities, Net 318M USD -10.5%
Operating Lease, Liability, Noncurrent 10.3M USD +16.9%
Other Liabilities, Noncurrent 38.6M USD +7.7%
Liabilities 1.37B USD -3.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31.4M USD -18.6%
Retained Earnings (Accumulated Deficit) 543M USD -4.15%
Stockholders' Equity Attributable to Parent 3.14B USD -0.35%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.14B USD -0.35%
Liabilities and Equity 4.5B USD -1.27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.9M USD -178%
Net Cash Provided by (Used in) Financing Activities 979K USD -7.82%
Net Cash Provided by (Used in) Investing Activities -33.7M USD -288%
Common Stock, Shares Authorized 315M shares 0%
Common Stock, Shares, Issued 217M shares +0.18%
Common Stock, Par or Stated Value Per Share 0.16 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.1M USD -422%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120M USD -32.6%
Operating Lease, Liability 15.4M USD +27.4%
Lessee, Operating Lease, Liability, to be Paid 18M USD +29.7%
Property, Plant and Equipment, Gross 417M USD +30.9%
Operating Lease, Liability, Current 5.1M USD +55.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.79M USD +58.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.26M USD +48.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +21.3%
Deferred Income Tax Expense (Benefit) -9.12M USD -1014%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.62M USD +45.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.45M USD +26.6%
Deferred Tax Assets, Operating Loss Carryforwards 5.58M USD +42.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 2.74M USD +190%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.28M USD +40.5%
Additional Paid in Capital 2.59B USD +0.68%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 94.9M USD +33.6%
Depreciation, Depletion and Amortization 29.8M USD +3.71%
Deferred Tax Assets, Net of Valuation Allowance 40.6M USD +63.5%
Interest Expense 42.2M USD
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%